MedPlus IPO

Medplus Health Services Limited IPO Review

Gangadi Madhukar Reddy launched the firm in 2006, and it is currently India’s second largest pharmacy retailer in terms of sales and number of outlets as of March 31, 2021. The company’s product line comprises pharmaceutical and wellness items such as pharmaceuticals, vitamins, medical equipment, and test kits, as well as (ii) fast-moving consumer goods such as toiletries, infant care products, soaps and detergents, and sanitizers.

As of March 31, 2021, the firm had a retail network of over 2,000 outlets spread over Tamil Nadu, West Bengal, Andhra Pradesh, Telangana, Karnataka, Odisha, and Maharashtra. In FY2021, its income from operations share of the organised pharmacy retail market in Chennai, Bangalore, Hyderabad, and Kolkata was around 30 percent, 29 percent, 30 percent, and 22 percent, respectively.

In FY2021, its annual income per shop was around INR15.9 million, compared to the domestic pharmacy retail company’s average revenue per store of approximately INR2.3 million.

As of September 30, 2021, its mature shops had a median payback duration of less than three years and a compounded average same-store sales increase of 8.3 percent on MRP from fiscal years 2019 to 2021. For the fiscal year 2021 and the six months ended 30 September 2021, its Store Level Operating EBITDA Margin for Mature Stores was 11.0 percent and 11.58 percent, respectively, while its Store Level Operating ROCE for Mature Stores was more than 60 percent.

Subscription Dates13 – 15 December 2021
Price BandINR780 – 796 per share
Fresh issueINR600 crore
Offer For SaleINR798.3 crore
Total IPO sizeINR1,398.3 crore
Minimum bid (lot size)18 shares
Face Value INR 2 per share
Retail Allocation35%
Listing OnNSE, BSE
 

FY2019

FY2020

Revenue

2,285.0

2,887.9

Expenses

2,262.2

2,858.5

Net income

10.5

(0.5)

Margin (%)

0.5

(0.02)

 

FY2021

H1 FY2022

Revenue

3,090.8

1,890.9

Expenses

2,995.7

1,807.3

Net income

64.1

68.2

Margin (%)

2.1

3.6

 

FY2019

FY2020

EPS

1.10

0.20

PE ratio

RONW (%)

4.09

0.41

ROCE (%)

19.87

EBITDA (%)

5.78

5.26

Debt/Equity

0.04

0.02

NAV

 

FY2021

EPS

5.88

PE ratio

132.65 – 135.37

RONW (%)

8.74

ROCE (%)

26.08

EBITDA (%)

7.76

Debt/Equity

0.21

NAV

65.37

Date

GMP

Kostak

Subject

To

 Sauda

17 Dec 2021

INR220

INR400

INR3,000

16 Dec 2021

INR200

INR380

INR2,800

15 Dec 2021

INR200

INR400

INR3,000

14 Dec 2021

INR250

INR400

INR3,200

13 Dec 2021

INR300

INR420

INR3,600

Listing Performance of Medplus Health Services Limited IPO

Listed On : Dec 23, 2021

Issue Price : 796 

Listing Day Close : 1120.85

Listing Day Gain/Loss (%) : 40.81%

NSE : NA

ISIN CODE : INE804L01022

BSE : NA

Angel One – Subscribe
Ashika Research – Not rated
BP Wealth – Subscribe
Canara Bank Securities – Avoid
Choice Broking – Subscribe
Elite Wealth – Subscribe
GEPL Capital – Subscribe
Hem Securities – Subscribe
ICICIdirect – Subscribe
KR Choksey – Subscribe
Marwadi Financial Services – Subscribe
Nirmal Bang – Subscribe for long term
Prabhudas Lilladher – Subscribe
Samco Securities – Subscribe for long term
SMC Global – 2.5/5
Ventura Securities – Subscribe

IPO Opening Date13 December 2021
IPO Closing Date15 December 2021
Finalisation of Basis of Allotment20 December 2021
Initiation of refunds21 December 2021
Transfer of shares to demat accounts22 December 2021
Listing Date23 December 2021

MedPlus Health Services Limited
Municipal No: 11-6-56,
Survey No. 257 & 258/1, C Block, III Floor,
Opp: Railway Siding (Moosapet),
Kukatpally, Hyderabad 500 037,
Telangana, India;
Phone: +91 040 6724 6724;
Email: cs@medplusindia.com
Website: www.medplusindia.com

KFin Technologies Private Limited
Selenium Tower B,
Plot No- 31 and 32, Financial District,
Nanakramguda, Serilingampally,
Hyderabad, Rangareedi 500 032,
Telangana, India
Phone: +91 40 6716 2222
Email: medplus.ipo@kfintech.com
Website: www.kfintech.com

Category

Shares Offered

Day 1

QIB

35,72,550

0.06

NII

26,79,414

0.16

Retail

62,51,965

1.29

Employees

71,225

0.76

Total

1,25,75,154

0.70

Category

Day 2

Day 3

QIB

0.09

111.90

NII

0.50

85.33

Retail

2.64

5.24

Employees

1.73

3.05

Total

1.46

52.59

Medplus Health Services Limited IPO FAQ's

Medplus Health Services Limited IPO is a main-board IPO of ₹₹780 to ₹796 per equity share of the face value of ₹2 aggregating up to [.] Eq Shares of ₹2
(aggregating up to ₹1,398.30 Cr). The issue is priced at ₹1000 to ₹1033 per equity share per equity share. The minimum order quantity is 18 Shares. The initial public offering (IPO) date Dec 13, 2021. The registrar for the IPO is Link Intime India Private Ltd. The shares are proposed for listing on the NSE and BSE.

The Medplus Health Services Limited IPO opening date is Dec 13, 2021. and the closing date is Dec 15, 2021.

Medplus Health Services Limited IPO Market lot size is 18 Shares and the minimum order quantity is 18 Shares.

The Basis of Allotment for Medplus Health Services Limited IPO will be done on Dec 20, 2021 and the allotted shares will be credited to your demat account by Dec 22, 2021. Check the Medplus Health Services Limited IPO allotment status.

The Medplus Health Services Limited IPO listing date is Dec 23, 2021.

Medplus Health Services Limited IPO can be submitted online using either UPI or ASBA as a payment method. The ASBA IPO application is available in your bank’s net banking. Brokers who do not provide banking services provide UPI IPO applications. Learn more about online IPO applications from Zerodha, Upstox, 5Paisa, Edelweiss, ICICI Bank, HDFC Bank, and SBI Bank.

Medplus Health Services Limited IPO Comments